Category: Regulatory & Safety

Balancing Scientific Value and Identification Risk in Anonymization

Eligibility Criteria in Clinical Trials

The Future of The Local Regulatory Affiliate: Adjusting To Global Strategies, Processes and Expectations

Positive Changes in the Latin American Clinical Trial Regulatory Environment

Seeking Ways to Ensure Participant Safety in First-in-Human Trials

Brexit’s Potential Regulatory Impact on the Pharmaceutical Industry

Major Clinical Trial Reforms Underway in China’s Regulatory Environment

Charting A New Course: Extractable and Leachable Testing

Experiences at the 11th Workshop on Recent Issues in Bioanalysis (WRIB)